Skip to main content

Aggregator

Role of complement and complement-targeted therapeutics in neurological diseases

6 hours 21 minutes ago
Complement comprises a group of plasma and membrane proteins that provide an effective bridging function for innate and adaptive humoral immunity. Understanding complement pathophysiology is fundamental given that inappropriate complement function in host defence can lead to infectious diseases and inefficient disposal of altered, damaged or senescent cells can lead to or enhance autoimmune neurological processes. Although the rising number of approved drugs targeting complement pathways remains...
Marinos C Dalakas

Priming of CD8<sup>+</sup> T cells by peripheral dendritic cells exacerbates tau-mediated neurodegeneration

6 hours 21 minutes ago
Alzheimer's disease and primary tauopathies are marked by changes in adaptive immunity, with increased brain CD8^(+) T cells correlating with tau pathology severity. However, how peripheral T cells get primed to enter the brain and contribute to tau-mediated neurodegeneration remains unclear. In different disease conditions, conventional type 1 dendritic cells (cDC1s) cross-present antigens to prime CD8^(+) T cells into effector cells. We show that tauopathy mice lacking cDC1s or antigen...
Hao Hu

Role of complement and complement-targeted therapeutics in neurological diseases

6 hours 21 minutes ago
Complement comprises a group of plasma and membrane proteins that provide an effective bridging function for innate and adaptive humoral immunity. Understanding complement pathophysiology is fundamental given that inappropriate complement function in host defence can lead to infectious diseases and inefficient disposal of altered, damaged or senescent cells can lead to or enhance autoimmune neurological processes. Although the rising number of approved drugs targeting complement pathways remains...
Marinos C Dalakas

One immune switch may help drive aging across the body

1 day 5 hours ago
Aging may be partly fueled by immune cells losing their ability to clear away damaged, inflammation-promoting cells. Blocking a single receptor restored that cleanup process in mice, reducing inflammation and helping their organs, muscles, and memory remain remarkably youthful.

Diagnostic performance of plasma pTau217 in genetically admixed South American populations

1 day 6 hours ago
Plasma pTau217 is a leading biomarker for Alzheimer's disease, but evidence from genetically admixed populations in low- and middle-income countries remains limited. We evaluated the diagnostic performance of pTau217 and pTau217/Aβ42 measured using Simoa technology in memory-clinic cohorts from Brazil (Cog-Aging-Study, n = 353) and Argentina (GeNED.ar, n = 134). Here we show that both biomarkers accurately identified cerebrospinal fluid (CSF)-defined amyloid pathology in Cog-Aging-Study-Brazil...
Pamela V Martino-Adami

Dilute electrolytes for suppressing metal anode corrosion during calendar aging and cycling in aqueous zinc batteries

1 day 6 hours ago
While numerous improvements in cycling stability have been demonstrated for next-generation battery chemistries with metallic anodes, their calendar aging (e.g., capacity loss during idle periods of rest) performance painfully lags behind and remains a critical bottleneck hindering their practical deployment. In contrast to their commercial counterparts, metallic anodes exhibit substantial capacity loss during calendar aging. Despite several recent studies exploring the underlying reasons for...
Haoyang Wu

Longer-lived mammals exhibit greater evolutionary conservatism and epigenetic modification at cancer-associated loci

1 day 6 hours ago
Peto's paradox underscores the puzzling disconnect between organismal lifespan, body size, and cancer incidence. Here, we investigate this relationship by examining the evolutionary rates of human cancer-associated sites across 58 mammalian species. While overall evolutionary rates at cancer-associated loci do not differ significantly between long-lived and short-lived species, cancer-associated sites show greater evolutionary conservation relative to non-cancer sites within long-lived mammals...
Xiaoxiao Zhang

Diagnostic performance of plasma pTau217 in genetically admixed South American populations

1 day 6 hours ago
Plasma pTau217 is a leading biomarker for Alzheimer's disease, but evidence from genetically admixed populations in low- and middle-income countries remains limited. We evaluated the diagnostic performance of pTau217 and pTau217/Aβ42 measured using Simoa technology in memory-clinic cohorts from Brazil (Cog-Aging-Study, n = 353) and Argentina (GeNED.ar, n = 134). Here we show that both biomarkers accurately identified cerebrospinal fluid (CSF)-defined amyloid pathology in Cog-Aging-Study-Brazil...
Pamela V Martino-Adami

Redox-dependent synaptic clustering of gephyrin

1 day 6 hours ago
Reactive oxygen species (ROS) have been demonstrated to play central functions as signaling molecules thus extending their role beyond oxidative stress in disease and aging. At inhibitory synapses the scaffolding protein gephyrin clusters glycine and GABA type A receptors. Postsynaptic gephyrin clustering is regulated by post-translational modifications such as phosphorylation, S-palmitoylation, and S-nitrosylation, which all critically impact its scaffolding function. Here, we show that...
Maria-Theresa Gehling

Natural history and clinical impact of epilepsy in adults with Down syndrome: a multicentre clinical study

1 day 6 hours ago
BACKGROUND: As individuals with Down syndrome age, they face high risks of Alzheimer's disease and epilepsy. With symptomatic Alzheimer's disease, late-onset myoclonic epilepsy in Down syndrome (LOMEDS) often emerges. We aimed to examine how epilepsy develops in Down syndrome, its timing relative to Alzheimer's disease symptom onset, and its effect on prognosis.
Lucía Maure-Blesa

Elderly Health Check-Up and Functional Disability or Death in Adults 75 to 84 Years: A Target Trial Emulation

1 day 6 hours ago
CONCLUSIONS AND IMPLICATIONS: The evidence is uncertain about the effect of initial EHC participation on the 5-year risk of functional disability or death; the point estimate is compatible with a modest benefit, but the 95% CI included the null. These findings neither support expansion nor justify discontinuation of the EHC program for preventing entry into LTC, and call for replication in additional cohorts before policy changes are considered.
Ryohei Yamamoto

Choose Home: Initial Evaluation of a Novel Home-Based Care Program After Subacute Rehabilitation

1 day 6 hours ago
Many older adults prefer aging in place, but complex medical and social care needs and fragmented care systems are barriers to maintaining independence at home. Choose Home was implemented at the Veteran Affairs Boston Health Care System in September 2023 to address a critical care gap for patients who seek to remain independent at home but are at high risk for acute care hospitalizations and institutionalization in long-term care facilities. This report describes a subpopulation (n = 16) of...
Chelsea M Lam